Open Beta
MetriLume

US marketsCDNA

SEC-sourced researchBeta

CDNA

CareDx, Inc.

Company comparison ↗

Data passport

CIK
0001217234
Exchange
Nasdaq
Business activity
— · SIC 8071
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 280,324,000.0000 USD; December 2024: 333,785,000.0000 USD; December 2025: 379,805,000.0000 USD379.8M USD0 USD0December 2023December 2024December 2025
CDNA · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023280,324,000.0000Feb 25, 2026
December 2024333,785,000.0000Feb 25, 2026
December 2025379,805,000.0000Feb 25, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025379,805,000.0000-21,354,000.000042,032,000.0000413,228,000.0000110,127,000.0000Feb 25, 2026
December 2024333,785,000.000052,549,000.000038,048,000.0000491,050,000.0000112,617,000.0000Feb 25, 2026
December 2023280,324,000.0000-190,284,000.0000-18,388,000.0000——Feb 25, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$379.81MDecember 2025Feb 25, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$333.79MDecember 2024Feb 25, 202610-K
Net incomeNetIncomeLoss-$21.35MDecember 2025Feb 25, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$42.03MDecember 2025Feb 25, 202610-K
Total assetsAssets$413.23MDecember 2025Feb 25, 202610-K
Total liabilitiesLiabilities$110.13MDecember 2025Feb 25, 202610-K

New filings

Explore methodology ↗